Status:
COMPLETED
A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers
Lead Sponsor:
Pfizer
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics (how the drug effects certain target sites of activity in the body) of escalating doses of ora...
Eligibility Criteria
Inclusion
- Healthy males between 18 and 55 years, inclusive.
- Healthy females between 18 and 44 years, inclusive.
Exclusion
- Evidence or history of clinically significant disease;
- Post-menopausal women;
- History of intolerance or significant adverse effects with glucocorticoids. therapy.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT00812825
Start Date
January 1 2009
End Date
July 1 2009
Last Update
August 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Brussels, Belgium, 1070